AI blood test could spare breast cancer patients unneeded chemo

NCT ID NCT04874064

First seen Dec 08, 2025 · Last updated May 09, 2026 · Updated 22 times

Summary

This study looks at whether artificial intelligence can help analyze tiny particles in the blood (called liquid biopsies) from people with triple negative breast cancer. The goal is to develop a test that tells doctors early on if the cancer has spread and how much tumor remains after surgery. About 130 participants who have already had chemotherapy will provide blood and tissue samples to help create this test.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Jewish General Hospital

    RECRUITING

    Montreal, Quebec, H3T 1E1, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • St. Joseph's Health Care London

    RECRUITING

    London, Ontario, N6A 4V2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Ottawa Hospital Cancer Center

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.